Latest Articles
Woman waited 17 years for an endometriosis diagnosis - ITVX
Woman waited 17 years for an endometriosis diagnosis ITVX
Published: March 3, 2026, 5:52 p.m.
Doctors missing endometriosis in many women: study - CTV News
Doctors missing endometriosis in many women: study CTV News
Published: March 3, 2026, 4:43 p.m.
TENS Improves Quality of Life and Reduces Analgesic Use in Endometriosis: Study - Medical Dialogues
TENS Improves Quality of Life and Reduces Analgesic Use in Endometriosis: Study Medical Dialogues
Published: March 3, 2026, 3:30 p.m.
Group for endometriosis creates awareness and support - 101.5 The Hawk
Group for endometriosis creates awareness and support 101.5 The Hawk
Published: March 3, 2026, 3:22 p.m.
PRM Partners with Endo Black, Inc. to Advance Equity in Endometriosis Care - Announces 'Healing Through Art” Community Event - The Manila Times
PRM Partners with Endo Black, Inc. to Advance Equity in Endometriosis Care - Announces 'Healing Through Art” Community Event The Manila Times
Published: March 3, 2026, 1:32 p.m.
PRM Partners with Endo Black, Inc. to Advance Equity in Endometriosis Care — Announces “Healing Through Art” Community Event - Yahoo Finance
PRM Partners with Endo Black, Inc. to Advance Equity in Endometriosis Care — Announces “Healing Through Art” Community Event Yahoo Finance
Published: March 3, 2026, 1:26 p.m.
CIAA Health and Mental Wellness Summit highlights fibroids and endometriosis in Black women - AFRO American Newspapers
CIAA Health and Mental Wellness Summit highlights fibroids and endometriosis in Black women AFRO American Newspapers
Published: March 3, 2026, 12:30 p.m.
New stats reveal near 10-year wait-time for endometriosis diagnosis in Wales - Rayo
New stats reveal near 10-year wait-time for endometriosis diagnosis in Wales Rayo
Published: March 3, 2026, 11:43 a.m.
Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening - Nature
Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening Nature
Published: March 3, 2026, 10:36 a.m.
KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS - The Manila Times
KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS The Manila Times
Published: March 3, 2026, 10:06 a.m.
Link copied to clipboard!